Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,232.95
+3.30 (0.15%)
At close: Apr 21, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 630.18 billion as of April 21, 2026. Its market cap has increased by 46.94% in one year.
Market Cap
630.18B
Enterprise Value
615.52B
Revenue
165.10B
Ranking
n/a
PE Ratio
59.17
Stock Price
2,232.95
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 630.18B, an increase of 54,731.71%. That is a compound annual growth rate of 28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 630.18B | 9.72% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.42T |
| Lupin | 1.06T |
| Dr. Reddy's Laboratories | 1.02T |
| Abbott India | 539.62B |
| GlaxoSmithKline Pharmaceuticals | 411.14B |
| J. B. Chemicals & Pharmaceuticals | 319.98B |
| AstraZeneca Pharma India | 213.00B |
| Granules India | 165.57B |